GoldenGolden
ArrowMark Partners

ArrowMark Partners

ArrowMark Partners is an SEC-registered investment adviser.

ArrowMark Partners is an investment management adviser in Colorado that focuses on alternative credit and growth equity asset classes. Founded in 2007 in Denver, Colorado. The firm invests in late stage venture stages and usually invest in Series B, Series C, Series D rounds. The notable investment portfolio of ArrowMark Partners includes Twilio, ORIC Pharmaceuticals, Inhibrx, Pulmonx, and SpringWorks Therapeutics.

As of December 2019, ArrowMark Partners has made 28 investments and had 11 exits. and actively looking for new investment opportunities. The company manages $18.9 billion in assets for traditional and customized investments.

Timeline

2007
Founded

People

Name
Role
LinkedIn

BRIAN SCHAUB, CFA

Portfolio Manager

Tony Yao

Portfolio Manager

CHAD MEADE

Portfolio Manager

DAVID CORKINS

Portfolio Manager

KAELYN ABRELL

Portfolio Manager

KAREN REIDY, CFA

Portfolio Manager

Michael Novoseller

Managing Director and Investment Committee Member

SANJAI BHONSLE

Portfolio Manager

Vipul Shah

Managing Director and Investment Committee Member

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

4D Molecular Therapeutics

ArcherDX

SpringWorks Therapeutics

Evolve Vacation Rental Network

Inhibrx

Lyra Therapeutics

NextCure

Orchard Therapeutics

ORIC Pharmaceuticals

Pulmonx

News

Title
Author
Date
Publisher
Description
binx health, inc
May 27, 2021
www.prnewswire.com:443
/PRNewswire/ -- binx health, a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people...
FinSMEs
November 16, 2020
FinSMEs
About | Advertise | Contact | Disclaimer | News | The Daily Deal Newsletter FinSMEs.com by FinSMEs is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.
Adagio Medical, Inc.
November 14, 2020
www.prnewswire.com:443
/PRNewswire/ -- Adagio Medical, Inc., un innovateur de premier plan pour le traitement de la fibrillation auriculaire (FA) et de la tachycardie ventriculaire...
Adagio Medical, Inc.
November 13, 2020
www.prnewswire.com:443
/PRNewswire/ -- Adagio Medical, Inc., un innovador líder para el tratamiento de la fibrilación atrial (FA) y taquicardia ventricular (TV), y desarrollador del...
Adagio Medical, Inc.
November 13, 2020
www.prnewswire.com:443
/PRNewswire/ -- Adagio Medical, Inc., a leading innovator for the treatment of atrial fibrillation (AF) and ventricular tachycardia (VT), and developer of the...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.